Gastroenterology. 2014 Jan;146(1):291-304.e1. doi: 10.1053/j.gastro.2013.11.004.
Pancreatic ductal adenocarcinoma is an aggressive malignancy with a high mortality rate. Proper determination of the extent of disease on imaging studies at the time of staging is one of the most important steps in optimal patient management. Given the variability in expertise and definition of disease extent among different practitioners as well as frequent lack of complete reporting of pertinent imaging findings at radiologic examinations, adoption of a standardized template for radiology reporting, using universally accepted and agreed on terminology for solid pancreatic neoplasms, is needed. A consensus statement describing a standardized reporting template authored by a multi-institutional group of experts in pancreatic ductal adenocarcinoma that included radiologists, gastroenterologists, and hepatopancreatobiliary surgeons was developed under the joint sponsorship of the Society of Abdominal Radiologists and the American Pancreatic Association. Adoption of this standardized imaging reporting template should improve the decision-making process for the management of patients with pancreatic ductal adenocarcinoma by providing a complete, pertinent, and accurate reporting of disease staging to optimize treatment recommendations that can be offered to the patient. Standardization can also help to facilitate research and clinical trial design by using appropriate and consistent staging by means of resectability status, thus allowing for comparison of results among different institutions.
胰腺导管腺癌是一种侵袭性恶性肿瘤，死亡率很高。在分期时的影像学研究中正确确定疾病的范围是优化患者管理的最重要步骤之一。鉴于不同从业者之间的专业知识和疾病范围的定义存在差异，以及影像学检查中经常缺乏对相关影像学发现的完整报告，因此需要采用一种标准化的影像学报告模板，使用通用的、被广泛认可的术语来描述胰腺实体瘤。在腹部放射学会和美国胰腺协会的联合赞助下，由胰腺导管腺癌多机构专家组撰写的一份关于标准化报告模板的共识声明得到了发展。采用这种标准化的影像学报告模板，通过提供完整、相关和准确的疾病分期报告，应该能够改善胰腺导管腺癌患者的治疗决策过程，从而为患者提供最佳的治疗建议。通过使用可切除性状态进行适当和一致的分期，标准化还可以帮助促进研究和临床试验设计，从而可以比较不同机构之间的结果。
